We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients from Jordan for healthcare practitioners.
The MHRA has today set out its strategic approach to artificial intelligence (AI)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Advice and guidance on the health needs of migrant patients from Nigeria for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Thailand for healthcare practitioners.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Advice and guidance on the health needs of migrant patients from Indonesia for healthcare practitioners.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Digital NHS Health Check to be rolled out across England next spring delivering an additional one million checks in the first 4 years.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and a recent National Patient Safety Alert asking organisations to put a plan in place to implement new regulatory measures for valproate.
Advice and guidance on the health needs of migrant patients from Yemen for healthcare practitioners.
The NHSBT/PHE epidemiology unit scans publications for emerging infection news relevant to blood, tissue and organ donation safety in the UK.
The Innovative Devices Access Pathway (IDAP), set for launch later in 2023, will be operated by the Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE), Health Technology Wales (HTW) and Scottish Health...
Advice and guidance on the health needs of migrant patients from the Czech Republic for healthcare practitioners.
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners
Advice and guidance on the health needs of migrant patients from Algeria for healthcare practitioners.
The AI-Airlock will assist in the development and deployment of software and AI medical devices, safely providing patients with earlier access to cutting edge innovations that improve care.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Sign up to the plant health newsletter to receive up-to-date forestry trade news.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).